{"symbol":"BSX","fiscalQuarter":"Q3-2021","reportDate":"2021-10-27","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2021","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 1.33%","keyNumbers":[{"metric":"EPS","actual":"$0.41","expected":"N/A","surprise":"+3.27%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on innovation and growth in key markets."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, no specific revenue guidance was provided."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.33%, likely due to the lack of revenue details and guidance, which may have left investors uncertain about future performance. The cautious tone from management suggests they are focused on long-term growth despite current market challenges.","metaDescription":"Boston Scientific (BSX) Q3 2021 earnings: EPS beat by 3.27%. Stock down 1.33%. Full breakdown."}}